Takara Bio Inc.

Otsuka Pharmaceutical Co. Ltd. has teamed up Seattle, US-based biotech Shape Therapeutics, Inc. (ShapeTX) to further expand its R&D capabilities related to gene therapies for eye disorders. The up

In a setback for the Japanese bioventure, AnGes, Inc. has discontinued a government-supported R&D project for an injected DNA plasmid vaccine for the original Wuhan strain of COVID-19. While the Osa

With plans to file the T-cell receptor (TCR) therapy afamitresgene autoleucel (afami-cel) for US Food and Drug Administration approval in the fourth quarter of 2022, Adaptimmune Therapeutics plc is

Japan has one of the largest single-country pharma markets in the world, a handful of major R&D-based companies with multiple innovative drugs sold around the globe, and a record of innovation that st